Translational Oncology

Article	Citations
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	154
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	152
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	137
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	107
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	91
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	88
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	87
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation	85
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	77
FUBP1 in human cancer: Characteristics, functions, and potential applications	77
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	69
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	64
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	61
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies	58
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	54
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers	53
HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse model	52
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	51
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	50
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	47
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	47
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	45
The double face of cold in cancer	43
Investigating the molecular mechanisms and clinical potential of APO+ endothelial cells associated with PANoptosis in the tumor microenvironment of hepatocellular carcinoma using single-cell sequencin	42
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	42

miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway	42
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	41
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	41
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	41
Development of a single-cell derived MDSCs signature score for prognostic risk stratification and therapeutic decision guidance in breast cancer	41
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	41
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	40
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis	40
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	38
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	37
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	36
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	36
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	36
CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription	35
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	34
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma	34
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy	32
A Glycerophospholipid Metabolism-Based Prognostic Model Guides Osteosarcoma Therapy	31
Penfluridol enhances anti-tumor immunity in colorectal cancer by inducing proteasome-mediated degradation of PD-L1 via the activation of AMPK	31
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma	31
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer	31
YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9	31
Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma	31
Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer	31
Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway	30
Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection	30
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma	30
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer	29
Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy	29
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models	28
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways	28
Currents status of radiotracers for breast cancer imaging in PET	28
CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy	27
Multiphase enhanced CT-based transformer for differential diagnosis and predicting surgical risk events of solid abdominal tumors in children	27
Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer	27
Nuclear protein in testis carcinoma of the lung	26
Liposomal sodium clodronate mitigates radiation-induced lung injury through macrophage depletion	26
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema	26
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer	25
Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy	25
miR-362-3p suppresses ovarian cancer by inhibiting LRP8	25
Acetophenone protection against cisplatin-induced end-organ damage	24
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1	24
Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines	24
Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature	24
Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma	24
Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma	24
Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer	23
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia	23
Prognostication of colorectal cancer liver metastasis by CE-based radiomics and machine learning	23

LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression	23
M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma	23
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting	23
Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer	23
The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review	23
Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma	22
Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry	22
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer	22
HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma	22
Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins	22
Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'”	22
Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A–PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1	21
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis	21
Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)	21
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis of clock circadian regulator with prognostic and immune microenvironment in thyroid cancer	21
Expression of MASTL (Greatwall) associates with good prognosis and response to radiotherapy in pharyngeal squamous cell carcinoma	21
Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes	21
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration	21
Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma	20
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance	20
poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells	20
Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma	20
CKAP4-mediated activation of FOXM1 via phosphorylation pathways regulates malignant behavior of glioblastoma cells	20
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach	20
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression	20
ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling	20
Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients	20
A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer	20
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis	20
A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity	20
Cancer is not a guest	19
Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis	19
IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response	19
Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology	19
Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer	19
The relationship between URG4 and clinicopathologic parameters and its effect on two-year survival in gastric carcinoma	19
Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological study	19
Extracellular vesicles as biomarkers for endometrial cancer – A systematic review	19
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation	19
Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach	19
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy	19
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma	19
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression	19
GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer	19
INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment	19
Generation of a competing endogenous RNA network and validation of BNIP1 expression in the lung of irradiated mice	19
Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis	18
Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features	18
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity	18
Circling back to epigenetic regulation in osteosarcoma: Comment on ‘Hsa_circ_0088212-mediated miR-520h/APOA1 axis inhibits the osteosarcoma progression’ by ‘ Hao Peng’	18
LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis	18
Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro	18
High-resolution anoscopy predictive modeling of anal canal cancer response after definitive chemoradiotherapy in COVID19 era	18
Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)	18
Propofol inhibits glioma growth by blocking the formation of the NF-κB/LGI4 feedback loop to activate TP53 self-transcription	18
Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study	17
Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway	17
Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy	17
Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics	17
Patient reported change in pain outcome among stage IV cancer patients with bone metastases following palliative radiotherapy: A prospective study from Ethiopia	17
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1	17
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma	17
Nuclear factor E2 p45-related factor (NRF2) and peroxiredoxin 6 tissular expression as prognostic biomarkers for advanced HPV-negative squamous cell carcinoma of the oropharynx	17
Cardiotoxicity of breast cancer drug treatments	17
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy	17
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth	17
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy	16
Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells	16
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4	16
NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα	16
Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma	16
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling	16
Dysregulated proton and sodium gradients highlight cancer invasion and proliferation	16
Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family	16
Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience><Translational Oncology, 26C (2022) 10	16
Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy	16
Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma	16
Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging	16
A Commentary on: Long-term outcomes of induction chemotherapy followed by intensity modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease	16
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cells	16

Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment	16
A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer	16
Identification of novel prognostic indicators for oral squamous cell carcinoma based on proteomics and metabolomics	15
Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer	15
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma	15
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations	15
Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer	15
Understanding the heterogeneity of pancreatic ductal adenocarcinoma	15
Individualized tumor-reactive T cells exhibit a potent anti-tumor response in prostate cancer	15
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor–related bone loss by promoting H-type vessel formation	15
lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop	15
Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer	15
Bmi-1 inhibition sensitizes head and neck cancer stem cells to cytotoxic chemotherapy	15
A mini-review-cancer energy reprogramming on drug resistance and immune response	15
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered	15
Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations	15
Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma	15
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer	15
The new Bruton’s tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres	15
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion	15
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes	14
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	14
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids	14
Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women	14
Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment	14
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade	14
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas	14
Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms	14
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers	14
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma	14
Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer	14
Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes	14
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II	14
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix	14
HER2 as a potential therapeutic target on quiescent prostate cancer cells	14
Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice	14
Circ-0008536 inhibits doxorubicin resistance in triple-negative breast cancer via the miR-382-5p/GGNBP2 axis	14
Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation	14
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma	14
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications	14
A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis	14
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase	14
Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer	14
RPL36A activates ERK pathway and promotes colorectal cancer growth	14
Camizestrant causes reversible pharmacological effects on retinal responses in rats	14
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines	13
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma	13
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer	13
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care	13
Early onset pancreatic cancer: A review	13
The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin	13
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction	13
The PI3K pathway is a downstream effector of NRF2 activation in the esophagus	13
CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer	13
Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation	13
Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer	13
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis	13
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images	13
Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors	13
RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization	13
Integrative multi-omics of matched primary and liver metastatic colorectal cancer organoids identifies putative molecular targets	13
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification	13
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer	13
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context	13
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3	13
Corrigendum to “Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells” [Translational Oncology 27 (2023) 1–9/101564]	13
A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications	13
Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma	13
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration	13
ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma	13
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma	13
Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer	13
Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma	13
Analysis of transition metal content in glioblastoma reveals association between iron and survival	13
Tebentafusp in first-line melanoma trials: An outperforming outlier	13
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	13
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	13
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	12
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review	12
APOA1 promotes tumor proliferation and migration and may be a potential pan-cancer biomarker and immunotherapy target	12
Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of β-hydroxybutyrate and polyunsaturated fatty acids	12
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors	12
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls	12
NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer	12
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study	12
Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer	12
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany	12
Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer	12
A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1	12
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	12
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway	12
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer	12
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation	12
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome	12
PTBP3 promotes tumorigenesis of glioblastoma by stabilizing Twist1	12